Biomarkers Market Size Worth $129.4 Billion By 2027 | CAGR: 13.7%

February 2020 | Report Format: Electronic (PDF)

Biomarkers Market Growth & Trends

The global biomarkers market size is expected to reach over USD 129.4 billion by 2027, according to a new study conducted by Grand View Research Inc. It is anticipated to exhibiting a CAGR of 13.7%, during the forecast period. Factors, such as increasing collaborations and funds for R&D activities, rising consumer awareness, a widening patient base, and technological advancements collectively augmenting market growth.

The drug discovery segment contributed the highest revenue in 2019. Pharmaceutical companies focus on extensive R&D initiatives for the development of targeted therapeutics. Coordinated strategic efforts on biomarker development remain a searing trend among drug manufacturers, academic research institutions, commercial R&D organizations, nonprofitable health foundations, and federal government biomedical regulatory and research agencies.

North America continued to lead the biomarkers market in 2019, driven by an amplifying demand for personalized medicines, high disease prevalence, and proactive government initiatives. It is expected to maintain its lead over the forecast period. Asia Pacific is positioned to witness the fastest CAGR, over the forecast period, spearheaded by India.

Some key market players include Abbott; F. Hoffmann-La Roche Ltd.; Qiagen; Siemens Healthcare Private Limited; Thermo Fisher Scientific, Inc.; Bio-Rad Laboratories, Inc.; Johnson & Johnson Services, Inc; Agilent Technologies, Inc.; and Epigenomics AG. The players are developing novel kits and therapies and drugs to target population in the areas with high unmet clinical needs.

 Request a free sample copy or view report summary: Biomarkers Market Report

Biomarkers Market Report Highlights

  • Safety biomarkers captured more than 41% market share in 2019, driven by increasing awareness regarding routine healthcare checkups and reduction in drug attrition

  • Validation biomarkers is expected to demonstrate the fastest CAGR through to 2027

  • Personalized medicine is likely to expand at a CAGR of 14.8% over the forecast period due to consumer awareness and preferences

  • Cancer dominated the disease segment in 2019, driven by a high disease burden and presence of a strong pipeline

  • Cardiovascular disease segment is projected to witness the fastest growth in the forthcoming years, supported by the growing obese population base and sedentary lifestyles

Biomarkers Market Segmentation

Grand View Research has segmented the global biomarkers market on the basis of type, application, disease, and region:

Biomarkers Type Outlook (Revenue, USD Million, 2015 - 2027)

  • Safety

  • Efficacy

  • Validation

Biomarkers Application Outlook (Revenue, USD Million, 2015 - 2027)

  • Diagnostics

  • Drug Discovery & Development

  • Personalized Medicine

  • Others

Biomarkers Disease Outlook (Revenue, USD Million, 2015 - 2027)

  • Cancer

  • Cardiovascular Disease

  • Neurological Disease

  • Immunological Disease

  • Others

Biomarkers Regional Outlook (Revenue, USD Million, 2015 - 2027)

  • North America

    • U.S.

    • Canada

  • Europe

    • U.K.

    • Germany

    • Spain

    • France

    • Italy

  • Asia Pacific

    • Japan

    • China

    • India

    • South Korea

    • Australia

  • Latin America

    • Brazil

    • Mexico

    • Argentina

  • MEA

    • South Africa

    • Saudi Arabia

    • UAE

Pricing & Purchase Options

Service Guarantee

  • Insured Buying

    This report has a service guarantee. We stand by our report quality.

  • Confidentiality

    Your transaction & personal information is safe and secure.

  • Custom research service

    Design an exclusive study to serve your research needs.

  • 24/5 Research support

    Get your queries resolved from an industry expert.

Buy Chapters or Sections

Avail customized purchase options to meet your research needs:

  • Buy sections of this report
  • Buy country level reports
  • Request for historical data
  • Request discounts available for Start-Ups & Universities

Related Market Research